Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 21, 2021 - Issue 5
Submit an article Journal homepage
463
Views
2
CrossRef citations to date
0
Altmetric
Drug Evaluation

Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMD

Lorenzo Ferro Desideria Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (Dinogmi), University of Genoa, ItalyView further author information
,
Carlo Enrico Traversoa Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (Dinogmi), University of Genoa, Italy;b Ospedale Policlinico San Martino IRCCS, Genoa, ItalyView further author information
&
Massimo Nicolòa Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (Dinogmi), University of Genoa, Italy;b Ospedale Policlinico San Martino IRCCS, Genoa, Italy;c Fondazione per La Macula Onlus, Genoa, ItalyCorrespondence[email protected]
View further author information
Pages 553-561 | Received 19 Feb 2021, Accepted 07 Apr 2021, Published online: 24 Apr 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Wen-Jing Ning, Xue Liu, Hong-Ye Zeng, Zhi-Qiang an, Wen-Xin Luo & Ning-Shao Xia. (2022) Recent progress in antibody-based therapeutics for triple-negative breast cancer. Expert Opinion on Drug Delivery 19:7, pages 815-832.
Read now
Lorenzo Ferro Desideri, Carlo Enrico Traverso & Massimo Nicolò. (2022) The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases. Expert Opinion on Therapeutic Targets 26:2, pages 145-154.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.